Skip to main content
Clinical Trials/NL-OMON29825
NL-OMON29825
Completed
N/A

Clinical evaluation of percutaneous implantation of the CoreValve aortic valve prosthesis. Safety and performance study on patients at high risk for surgical valve replacement. - CoreValve generation 3

CoreValve0 sites30 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
aorta valve stenosis
Sponsor
CoreValve
Enrollment
30
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
CoreValve

Eligibility Criteria

Inclusion Criteria

  • significant aortic valve stenosis, euroscore higher than 15 and/or age higher than 75 years

Exclusion Criteria

  • previous aortic valve replacement, recent or evalutive CVA, kreatine clearance less than 20ml per minute, mitral and tricuspid insuffiency more than grade 2

Outcomes

Primary Outcomes

Not specified

Similar Trials